According to research by Niteesh K. Choudhry, M.D., Ph.D., associate professor at Harvard University and associate physician at Brigham and Women's Hospital in Boston, presented at the American Heart Association's Scientific Sessions 2011, heart attack patients who got free medications had lower rates of rehospitalization for heart attack or heart failure compared to patients who had prescription co-pays.
Patients who paid nothing for their cholesterol-lowering and other medications shown to improve patient outcomes after a heart attack were 4% to 6% more likely to take them than the those who had co-pays.
Researchers found that 17.6% of those with free medications had a major cardiac event or underwent revascularization, compared to 18.8% of those with co-pays. This difference was not statistically significant, but when assessed separately from revascularization, there was a significant reduction in the rate of major cardiac events. After about a year, the rate of heart attacks, angina and heart failure dropped 14% in the patients getting free medications.
Furthermore, patients saved 26% on their overall out-of-pocket healthcare costs. Because they had improved health, they paid fewer copayments for doctor's visits in addition to the savings from no drug co-pays, researchers said.
Read more at: http://tinyurl.com/6psllxr
Source: Presented November 14 at the American Heart Association’s Scientific Sessions 2011.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More